Beta
86019

TLR4/NF-KB SIGNALING PATHWAY IS A KEY PATHOGENIC EVENT OF LUNG INJURY IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN A MOUSE MODEL

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

Biochemistry and pathological chemistry

Abstract

Interstitial lung disease (ILD) comprises many chronic lung diseases with various degrees of inflammation and fibrosis. Idiopathic pulmonary fibrosis (IPF) is a specific lung disorder characterized by progressive fibrosis leading to end-stage lung disease, respiratory failure, and fatal outcome. The toll like receptor (TLR) family serves as an important regulatory role in the innate immune system. Recently, several studies implicated TLR signaling in the proinflammatory response of a variety of endogenous and exogenous stimuli within the lung. Innate immune activation via TLR4 contributes to lung injuries but its role in tissue remodeling during ILD is still unclear. The current study aimed to investigate role of lungTLR4, nuclear factor kappa B (NF-kB), transforming growth factor-β (TGF-β) and interleukin 1B (IL1B) in the pathogenesis of IPF. We examined the expression pattern of TLR4, NF-kB, TGF and IL1B after one and three weeks of bleomycin-induced pulmonary fibrosis in a mouse model. Expression of TLR4 and its downstream modulator NF-kB were markedly elevated. Consequently, expression of profibrogenic cytokine TGF-β and inflammatory cytokines IL1B were induced in all grades of pulmonary fibrosis of mice model. Furthermore, there was an increase in interstitial collagen deposition side by side with induction of the activity of some pathophysiological enzymes and uric acid. In conclusion, our findings exhibit the importance of TLR4/NF-kB as significant mediators in fibrotic lung injury and open the door for future studies that can improve the lifestyle of IPF patients.

DOI

10.21608/ajps.2020.86019

Keywords

TLR4, TGF-β, lung, Bleomycin, fibrosis, IL1B, ILD, IPF, NF-kB

Authors

First Name

Mostafa

Last Name

Sabry

MiddleName

-

Affiliation

Department of Biochemistry, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt.

Email

-

City

-

Orcid

-

Volume

61

Article Issue

1

Related Issue

12941

Issue Date

2020-03-01

Receive Date

2020-04-29

Publish Date

2020-03-01

Page Start

92

Page End

103

Print ISSN

1110-1644

Online ISSN

2535-1958

Link

https://ajps.journals.ekb.eg/article_86019.html

Detail API

https://ajps.journals.ekb.eg/service?article_code=86019

Order

7

Publication Type

Journal

Publication Title

Al-Azhar Journal of Pharmaceutical Sciences

Publication Link

https://ajps.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023